RY 169.88 -1.0542% SHOP 144.59 -0.959% TD 77.85 -0.1667% ENB 59.62 -0.5505% BN 78.53 -0.971% TRI 223.92 -0.2495% CNQ 47.03 -0.0213% CP 102.49 -0.5627% CNR 147.77 -0.8787% BMO 131.32 -0.0685% BNS 78.4 0.0255% CSU 4463.7002 0.6222% CM 90.42 0.6344% MFC 44.91 -1.3184% ATD 77.0 -0.7604% NGT 60.01 -0.4149% TRP 68.0 -2.2989% SU 56.965 -0.4282% WCN 260.14 -0.653% L 176.45 0.7135%
Last update at 2024-11-20T19:24:00Z
Three TSX Stocks Estimated To Be Trading Below Intrinsic Value
Thu 19 Sep 24, 12:02 PMTSX Stocks That May Be Trading Below Fair Value Estimates For September 2024
Wed 18 Sep 24, 12:03 PM3 TSX Stocks Estimated To Be Trading At Up To 48% Discount
Mon 09 Sep 24, 12:05 PM3 TSX Stocks That Could Be Undervalued Based On Current Estimates
Thu 05 Sep 24, 12:04 PM3 TSX Stocks Estimated To Be Undervalued For September 2024
Mon 02 Sep 24, 12:06 PMUndervalued TSX Stocks Offering Potential Value In August 2024
Fri 30 Aug 24, 12:08 PMTop TSX Stocks That May Be Undervalued In August 2024
Wed 28 Aug 24, 12:07 PMTop 3 TSX Stocks That Could Be Undervalued In August 2024
Mon 26 Aug 24, 12:08 PMAugust 2024's Top TSX Stocks Estimated Below Fair Value
Fri 23 Aug 24, 12:02 PM3 TSX Stocks Trading At Discounts Of Up To 42.7%
Wed 14 Aug 24, 12:08 PMBreakdown | 2024-06-30 | 2023-12-31 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-12-31 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
Income before tax | -10.69843M | -10.64765M | -12.83682M | -12.83682M | -16.51667M |
Minority interest | - | - | - | - | - |
Net income | -11.66501M | -10.60018M | -12.79817M | -12.79817M | -15.54059M |
Selling general administrative | 23.16M | 21.80M | 21.12M | 21.12M | 17.10M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 20.75M | 17.85M | 21.29M | 15.43M | 9.38M |
Reconciled depreciation | 11.01M | 9.57M | 8.89M | 8.89M | 7.38M |
Ebit | - | - | -10.50684M | -10.98309M | -16.98668M |
Ebitda | - | - | -1.61641M | - | -9.61061M |
Depreciation and amortization | - | - | 8.89M | - | 7.38M |
Non operating income net other | - | - | - | - | - |
Operating income | -10.50837M | -10.25061M | -11.70831M | -11.70831M | -16.70063M |
Other operating expenses | - | - | 133.68M | - | 109.03M |
Interest expense | 1.13M | 1.44M | 1.47M | 0.73M | 1.22M |
Tax provision | 0.97M | -0.04747M | -0.03865M | -0.03865M | -0.97608M |
Interest income | 1.21M | 1.59M | 1.00M | 1.00M | 0.46M |
Net interest income | 0.08M | 0.15M | 0.06M | 0.06M | -0.76160M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | - | - | -0.03865M | -0.03865M | -0.97608M |
Total revenue | 128.60M | 124.26M | 122.70M | 122.72M | 92.33M |
Total operating expenses | 139.11M | 134.51M | 32.27M | 133.68M | 26.08M |
Cost of revenue | 107.85M | 106.41M | 101.41M | 107.29M | 82.96M |
Total other income expense net | -0.26885M | -0.54594M | -1.91708M | -1.91708M | 0.18M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -11.66501M | -10.60018M | -12.79817M | -12.79817M | -15.54059M |
Net income applicable to common shares | - | - | -12.79817M | -12.79817M | -15.54059M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 | 2021-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 | 2021-12-31 |
Total assets | 159.69M | 165.25M | 165.25M | 167.26M | 167.26M |
Intangible assets | 13.25M | 14.52M | 14.52M | 7.26M | 7.26M |
Earning assets | - | - | - | - | - |
Other current assets | 1.66M | 1.33M | 1.33M | 1.13M | 1.13M |
Total liab | 52.04M | 48.97M | 48.97M | 49.73M | 49.73M |
Total stockholder equity | 107.65M | 116.28M | 116.28M | 117.53M | 117.53M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 0.42M | 8.64M | 6.40M | 6.83M | 6.83M |
Common stock | - | 180.31M | 180.31M | 169.35M | 169.35M |
Capital stock | 182.68M | 180.31M | 180.31M | 169.35M | 169.35M |
Retained earnings | -80.72582M | -69.06685M | -69.06685M | -56.02013M | -56.02013M |
Other liab | - | 3.51M | 3.51M | 2.83M | 2.83M |
Good will | 1.92M | 1.92M | 1.92M | 1.92M | 1.92M |
Other assets | - | 2.55M | 2.55M | 0.18M | 0.18M |
Cash | 26.50M | 36.21M | 36.21M | 51.23M | 51.23M |
Cash and equivalents | - | - | - | 51.23M | 51.23M |
Total current liabilities | 33.67M | 29.73M | 29.73M | 27.87M | 27.87M |
Current deferred revenue | - | 1.02M | - | 0.54M | 0.54M |
Net debt | - | -11.63750M | - | -21.89944M | -21.89944M |
Short term debt | - | 8.84M | - | 10.31M | 10.31M |
Short long term debt | 3.60M | 6.04M | 6.04M | 7.82M | 7.82M |
Short long term debt total | - | 24.57M | - | 29.33M | 29.33M |
Other stockholder equity | - | 5.03M | 5.03M | 4.20M | 4.20M |
Property plant equipment | - | 70.82M | 70.82M | 62.71M | 62.71M |
Total current assets | 70.16M | 75.43M | 75.43M | 90.95M | 90.95M |
Long term investments | - | 0.00000M | 0.00000M | 4.24M | 4.24M |
Net tangible assets | - | 99.83M | 99.83M | 108.36M | 108.36M |
Short term investments | - | - | - | - | - |
Net receivables | 20.90M | 20.61M | 20.61M | 21.08M | 21.08M |
Long term debt | 4.27M | 3.32M | 3.32M | 6.28M | 6.28M |
Inventory | 17.03M | 17.28M | 17.28M | 17.51M | 17.51M |
Accounts payable | 12.74M | 11.23M | 11.23M | 10.20M | 10.20M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | 5.03M | - | 4.20M | 4.20M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | - | 0.25M | - | 0.18M | 0.18M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 89.54M | 89.82M | 89.82M | 76.31M | 76.31M |
Capital lease obligations | 12.97M | 15.22M | 15.22M | 15.23M | 15.23M |
Long term debt total | - | - | - | 19.02M | 19.02M |
Breakdown | 2024-06-30 | 2023-12-31 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-12-31 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
Investments | -10.64823M | -8.24748M | -1.00000M | -1.00000M | -1.00000M |
Change to liabilities | - | - | 2.90M | 2.90M | -2.15295M |
Total cashflows from investing activities | - | - | -9.83537M | -9.83537M | -5.74022M |
Net borrowings | - | - | -8.32726M | -8.32726M | -3.59940M |
Total cash from financing activities | -3.49834M | -9.34248M | -7.66471M | -7.66471M | 26.55M |
Change to operating activities | - | - | -0.10042M | -0.10042M | -0.44290M |
Net income | -11.66501M | -10.60018M | -12.79817M | -12.79817M | -15.54059M |
Change in cash | -9.72480M | -13.85362M | -15.02157M | -15.02157M | 0.71M |
Begin period cash flow | 36.21M | 42.77M | 51.23M | 51.23M | 50.52M |
End period cash flow | 26.50M | 28.92M | 36.21M | 36.21M | 51.23M |
Total cash from operating activities | 4.42M | 3.74M | 2.45M | 2.45M | -20.11458M |
Issuance of capital stock | - | - | 0.00000M | 0.00000M | 30.00M |
Depreciation | 11.01M | 9.57M | 8.89M | 8.89M | 7.38M |
Other cashflows from investing activities | - | - | 0.33M | 0.33M | -0.12475M |
Dividends paid | - | - | - | - | - |
Change to inventory | 0.30M | 1.73M | 0.42M | 0.42M | -4.08535M |
Change to account receivables | -3.14943M | 1.24M | 0.82M | 0.82M | -4.55608M |
Sale purchase of stock | - | - | 0.69M | 0.69M | 30.90M |
Other cashflows from financing activities | - | - | 0.66M | -0.02465M | 4.64M |
Change to netincome | - | - | 2.31M | 2.31M | -0.25144M |
Capital expenditures | 9.78M | 6.61M | 8.17M | 6.41M | 4.06M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | 1.93M | 3.89M | 4.04M | 4.04M | -11.69861M |
Stock based compensation | 1.56M | 1.20M | 1.12M | 1.12M | 0.70M |
Other non cash items | 0.83M | 0.80M | 1.31M | 0.80M | 0.07M |
Free cash flow | -5.35368M | -2.87398M | -5.72321M | -5.72321M | -24.17327M |
Sector: Basic Materials Industry: Chemicals
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
GRA NanoXplore Inc |
-0.05 2.20% | 2.22 | - | 833.33 | 3.12 | 3.85 | 3.05 | 126.52 |
MX Methanex Corporation |
-0.345 0.56% | 61.74 | 19.97 | 9.41 | 1.07 | 1.43 | 1.44 | 6.91 |
NanoXplore Inc., a graphene company, manufactures and supplies graphene powder for use in industrial markets in Australia. It operates through two segments: Advanced materials, plastics and composite products and Battery cells. The company offers graphene-based solutions, including GrapheneBlack powder and graphene-enhanced masterbatch pellets. It also provides standard and custom graphene-enhanced plastic and composite products to customers in transportation, packaging, electronics, and other industrial sectors. In addition, the company offers silicon-graphene-enhanced Li-ion battery for the electric vehicle and grid storage markets. NanoXplore Inc. was founded in 2011 and is headquartered in Montreal, Canada.
4500 Thimens Boulevard, Montreal, QC, Canada, H4R 2P2
Name | Title | Year Born |
---|---|---|
Dr. Soroush Nazarpour B.Sc, M.Sc, Ph.D. | Founder, Pres, CEO & Director | 1986 |
Mr. Rocco Marinaccio | Chief Operating Officer | NA |
Mr. Pedro Azevedo | Chief Financial Officer | NA |
Martin Gagne | Director of Investor Relations | NA |
Ms. Catherine Frigon Ll.B., Mba | Gen. Counsel, VP & Corp. Sec. | 1965 |
Mr. Jacques Poulin BESc, MBA | VP of Sales & Bus. Devel. | NA |
Dr. Francis Nedvidek Ph.D., Laser Physics, PEng Ontario | GM-European Subsidiary & Advisory Board Member | 1958 |
Dr. Soroush Nazarpour B.Sc, M.Sc, Ph.D. | Founder, President, CEO & Director | 1986 |
Mr. Martin Gagne | Director of Investor Relations | NA |
Sophie Rossignol | General Counsel | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.